Cardiovascular risk associated with nonsteroidal anti-inflammatory drug use in individuals with and without hypertension: a case-crossover study
Drugs & Therapy Perspectives · 23.06.2026 · 42 (2) · 491-499
DOI: 10.1007/s40267-026-01258-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs & Therapy Perspectives, online erschienen am 23.06.2026. Verfasst von Usama Sikandar und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
It is uncertain whether the relative increase in cardiovascular risk associated with non-steroidal anti-inflammatory drug (NSAID) use differs according to hypertension status.
Objective
The aim of this study was to investigate the association between NSAID use and major adverse cardiovascular events (MACE) in individuals with never, former, and current hypertension.
Methods
We conducted a case-crossover study including all first-time respondents to the Danish National Health Surveys of 2010, 2013, or 2017, without prior cardiovascular disease, who experienced a MACE from survey completion through 2021. We defined MACE as a composite of myocardial infarction, ischemic stroke, heart failure, atrial fibrillation or flutter, and cardiovascular death. We used conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between use of ibuprofen, naproxen, or diclofenac and MACE, and stratified the analyses by hypertension status (never, former, or current). We obtained information on NSAID use and MACE from nationwide Danish health registries.
Results
When comparing ibuprofen use with non-use, the ORs (95% CI) were 1.31 (1.13–1.52) for never hypertension, 1.85 (1.32–2.57) for former hypertension, and 1.39 (1.17–1.65) for current hypertension. For naproxen, ORs were 1.51 (0.71–3.23) for never hypertension, 1.96 (0.54–7.17) for former hypertension, and 2.35 (1.16–4.74) for current hypertension. For diclofenac, ORs were 1.48 (0.84–2.60) for never hypertension, 1.84 (0.53–6.37) for former hypertension, and 1.50 (0.82–2.74) for current hypertension.
Conclusions
The NSAID use-associated cardiovascular risk was not modified by hypertension status.
Zitieren
APA
Sikandar, U., Bonnesen, K., & Schmidt, M. (2026). Cardiovascular risk associated with nonsteroidal anti-inflammatory drug use in individuals with and without hypertension: a case-crossover study. Drugs & Therapy Perspectives, 42(2), 491-499. https://doi.org/10.1007/s40267-026-01258-5
Vancouver
Sikandar U, Bonnesen K, Schmidt M. Cardiovascular risk associated with nonsteroidal anti-inflammatory drug use in individuals with and without hypertension: a case-crossover study. Drugs & Therapy Perspectives. 2026;42(2):491-499. doi:10.1007/s40267-026-01258-5
BibTeX
@article{Sikandar2026,
author = {Sikandar, Usama and Bonnesen, Kasper and Schmidt, Morten},
title = {Cardiovascular risk associated with nonsteroidal anti-inflammatory drug use in individuals with and without hypertension: a case-crossover study},
journal = {Drugs & Therapy Perspectives},
year = {2026},
volume = {42},
number = {2},
pages = {491--499},
doi = {10.1007/s40267-026-01258-5}
}
EUVIMED